{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:18:21Z","timestamp":1792603101221,"version":"4.5.0"},"reference-count":59,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatitis C virus (HCV) infection affects ceramide metabolism, and, here, we have evaluated associations of eight serum ceramide species with viral load, viral genotype, and disease markers in 178 patients with chronic HCV. In this cohort, ceramide d18:1;O2\/16:0 was higher in the serum of the 20 diabetic patients compared to the patients without this complication. Moreover, ceramide d18:1;O2\/24:0 was negatively correlated with age. Of note, all but ceramide d18:1;O2\/16:0 and 26:0 were diminished in the serum of patients with liver cirrhosis and, with the exception of ceramide d18:1;O2\/16:0, were negatively correlated with the model for end-stage liver disease (MELD) score. Most of the serum ceramides are carried in low-density lipoprotein (LDL), which rises following effective direct-acting antiviral (DAA) therapy. Ceramide d18:1;O2\/24:0 recovered in parallel with LDL, whereas ceramide d18:1;O2\/18:0 declined. Genotype-3-infected patients had the lowest ceramide levels, which were comparable to other genotypes after DAA treatment. Notably, ceramide d18:1;O2\/23:0 and 24:0 were negatively correlated with the MELD score in patients with liver cirrhosis at the end of DAA therapy. Long-chain (LC) ceramides show adverse effects, whereas very-long-chain (VL) species have protective functions in the liver. The ratio of VL\/LC ceramides was higher in non-cirrhosis patients than cirrhosis patients and further increased at the end of therapy in this subgroup. In summary, our study shows that serum ceramide levels are related to liver cirrhosis and viral genotype. Whether the more favorable serum ceramide profile in non-cirrhosis patients, before and after DAA therapy, is of pathophysiological importance needs further investigation.<\/jats:p>","DOI":"10.3390\/ijms23179806","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T21:01:31Z","timestamp":1661806891000},"page":"9806","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Serum Ceramide Species Are Associated with Liver Cirrhosis and Viral Genotype in Patients with Hepatitis C Infection"],"prefix":"10.3390","volume":"23","author":[{"given":"Marcus","family":"H\u00f6ring","sequence":"first","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4891-0348","authenticated-orcid":false,"given":"Georg","family":"Peschel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University Hospital Regensburg, 93053 Regensburg, Germany"},{"name":"Department of Internal Medicine, Klinikum F\u00fcrstenfeldbruck, 82256 F\u00fcrstenfeldbruck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Grimm","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Krautbauer","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Weigand","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University Hospital Regensburg, 93053 Regensburg, Germany"},{"name":"Department of Gastroenterology, Gemeinschaftsklinikum Mittelrhein, 56073 Koblenz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.3748\/wjg.v24.i47.5297","article-title":"Hepatitis C: From inflammatory pathogenesis to anti-inflammatory\/hepatoprotective therapy","volume":"24","author":"Li","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz, M. (2021). Hepatitis C Virus Uses Host Lipids to Its Own Advantage. Metabolites, 11.","DOI":"10.3390\/metabo11050273"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000339206","article-title":"Lipid serum profile in patients with viral liver cirrhosis","volume":"21","author":"Vere","year":"2012","journal-title":"Med. Princ. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/599371","article-title":"Hepatitis C virus infection and the risk of coronary disease","volume":"49","author":"Butt","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.23219","article-title":"Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up","volume":"50","author":"Corey","year":"2009","journal-title":"Hepatology"},{"key":"ref_6","first-page":"156","article-title":"Changes in serum LDL, PCSK9 and microRNA-122 in patients with chronic HCV infection receiving Daclatasvir\/Asunaprevir","volume":"10","author":"Ichikawa","year":"2019","journal-title":"Biomed. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Peschel, G., Grimm, J., Gulow, K., Muller, M., Buechler, C., and Weigand, K. (2020). Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury. Diagnostics, 10.","DOI":"10.3390\/diagnostics10110974"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.3748\/wjg.v22.i46.10226","article-title":"Genotype specific peripheral lipid profile changes with hepatitis C therapy","volume":"22","author":"Pedersen","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","article-title":"Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease","volume":"126","author":"Lonardo","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.dld.2020.11.001","article-title":"Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)","volume":"53","author":"Cespiati","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/jvh.13381","article-title":"Response to \u2018hepatitis C cure improved patient-reported outcomes in patients with and without liver fibrosis in a prospective study at a large urban medical center\u2019","volume":"27","author":"Sung","year":"2020","journal-title":"J. Viral Hepat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"158658","DOI":"10.1016\/j.bbalip.2020.158658","article-title":"Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma","volume":"1865","author":"Buechler","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hajduch, E., Lachkar, F., Ferre, P., and Foufelle, F. (2021). Roles of Ceramides in Non-Alcoholic Fatty Liver Disease. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040792"},{"key":"ref_15","first-page":"419","article-title":"Ceramide and Sphingosine 1-Phosphate in Liver Diseases","volume":"43","author":"Park","year":"2020","journal-title":"Mol. Cells"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/hep.27587","article-title":"Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection","volume":"61","author":"Grammatikos","year":"2015","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbalip.2014.04.007","article-title":"Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease","volume":"1841","author":"Grammatikos","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Grammatikos, G., Ferreiros, N., Waidmann, O., Bon, D., Schroeter, S., Koch, A., Herrmann, E., Zeuzem, S., Kronenberger, B., and Pfeilschifter, J. (2015). Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138130"},{"key":"ref_19","first-page":"285","article-title":"The relationship between lipid profile and severity of liver damage in cirrhotic patients","volume":"10","author":"Ghadir","year":"2010","journal-title":"Hepat. Mon."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1590\/S0004-28032015000300011","article-title":"Lipid profile of cirrhotic patients and its association with prognostic scores: A cross-sectional study","volume":"52","author":"Bassani","year":"2015","journal-title":"Arq. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.dld.2021.04.035","article-title":"Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt","volume":"53","author":"Ballester","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3748\/wjg.v16.i11.1397","article-title":"Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis","volume":"16","author":"Jiang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bbalip.2016.08.016","article-title":"Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain sphingolipid species","volume":"1861","author":"Montgomery","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bbalip.2013.08.019","article-title":"Ceramide synthases as potential targets for therapeutic intervention in human diseases","volume":"1841","author":"Park","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"684448","DOI":"10.3389\/fendo.2021.684448","article-title":"Circulating Ceramides-Are Origins Important for Sphingolipid Biomarkers and Treatments?","volume":"12","author":"Mah","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e007931","DOI":"10.1161\/JAHA.117.007931","article-title":"Ceramide Remodeling and Risk of Cardiovascular Events and Mortality","volume":"7","author":"Peterson","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.7150\/ijms.43079","article-title":"Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges","volume":"17","author":"Zeng","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Graf, C., Welzel, T., Bogdanou, D., Vermehren, J., Beckel, A., Bojunga, J., Friedrich-Rust, M., Dietz, J., Kubesch, A., and Mondorf, A. (2020). Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092702"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/liv.14178","article-title":"Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response","volume":"39","author":"Mucke","year":"2019","journal-title":"Liver Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-6135.2004.00403.x","article-title":"Improving liver allocation: MELD and PELD","volume":"4","author":"Freeman","year":"2004","journal-title":"Am. J. Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/CH-211193","article-title":"Liver stiffness assessed by shear-wave elastography declines in parallel with immunoregulatory proteins in patients with chronic HCV infection during DAA therapy","volume":"79","author":"Peschel","year":"2021","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00261-019-02031-1","article-title":"Diagnostic accuracy of acoustic radiation force impulse elastography (ARFI) in comparison to other non-invasive modalities in staging of liver fibrosis in chronic HCV patients: Single-center experience","volume":"44","author":"Alem","year":"2019","journal-title":"Abdom. Radiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4254\/wjh.v9.i8.436","article-title":"Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C","volume":"9","author":"Andrade","year":"2017","journal-title":"World J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Butt, A.A., Yan, P., Simon, T.G., Chung, R.T., Abou-Samra, A.B., and ERCHIVES Study Team (2015). Changes in circulating lipids level over time after acquiring HCV infection: Results from ERCHIVES. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1268-2"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hashimoto, S., Yatsuhashi, H., Abiru, S., Yamasaki, K., Komori, A., Nagaoka, S., Saeki, A., Uchida, S., Bekki, S., and Kugiyama, Y. (2016). Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163644"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.prostaglandins.2017.06.004","article-title":"Associations of systemic sphingolipids with measures of hepatic function in liver cirrhosis are related to cholesterol","volume":"131","author":"Krautbauer","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2893.2011.01481.x","article-title":"Role of hepatitis C virus genotype 3 in liver fibrosis progression\u2014A systematic review and meta-analysis","volume":"18","author":"Probst","year":"2011","journal-title":"J. Viral Hepat."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3949\/ccjm.71.Suppl_3.S13","article-title":"Retreatment of patients who do not respond to initial therapy for chronic hepatitis C","volume":"71","author":"Shiffman","year":"2004","journal-title":"Cleve Clin. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2125.2006.02741.x","article-title":"Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin","volume":"62","author":"Snoeck","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1080\/00365520802245395","article-title":"Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis","volume":"43","author":"Syed","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"100479","DOI":"10.1016\/j.jhepr.2022.100479","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fendo.2019.00665","article-title":"Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats with Non-alcoholic Fatty Liver Disease","volume":"10","author":"Jiang","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_45","first-page":"756","article-title":"Cirrhosis and chronic liver failure: Part I. Diagnosis and evaluation","volume":"74","author":"Heidelbaugh","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ebiom.2019.10.056","article-title":"Cirrhosis-associated immune dysfunction: Novel insights in impaired adaptive immunity","volume":"50","author":"Liaskou","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/s41467-022-29363-9","article-title":"Long-chain ceramides are cell non-autonomous signals linking lipotoxicity to endoplasmic reticulum stress in skeletal muscle","volume":"13","author":"McNally","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1194\/jlr.RA119000446","article-title":"Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice","volume":"61","author":"Correnti","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2174\/187152012800228689","article-title":"Hepatocarcinogenesis and ceramide\/cholesterol metabolism","volume":"12","author":"Morales","year":"2012","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"18095","DOI":"10.18632\/oncotarget.7741","article-title":"Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma","volume":"7","author":"Grammatikos","year":"2016","journal-title":"Oncotarget"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.26015","article-title":"Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes","volume":"57","author":"Park","year":"2013","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4254\/wjh.v3.i5.99","article-title":"Insulin resistance and chronic liver disease","volume":"3","author":"Kawaguchi","year":"2011","journal-title":"World J. Hepatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2010.04.035","article-title":"Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis","volume":"53","author":"Nkontchou","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_54","unstructured":"European Association for the Study of the Liver, Clinical Practice Guidelines Panel: Chair, EASL Governing Board Representative, and Panel Members (2020). EASL recommendations on treatment of hepatitis C: Final update of the series. J. Hepatol., 73, 1170\u20131218."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e16270","DOI":"10.1097\/MD.0000000000016270","article-title":"Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice","volume":"98","author":"Yen","year":"2019","journal-title":"Medicine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0022-2275(20)33398-8","article-title":"Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS\/MS)","volume":"40","author":"Liebisch","year":"1999","journal-title":"J. Lipid Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbalip.2004.09.003","article-title":"High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm","volume":"1686","author":"Liebisch","year":"2004","journal-title":"Biochim. Biophys. Acta"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/17\/9806\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:19:33Z","timestamp":1760141973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/17\/9806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":59,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijms23179806"],"URL":"https:\/\/doi.org\/10.3390\/ijms23179806","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]}}}